These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 2192006

  • 21. Selectivity of human T lymphotropic virus type-1 (HTLV-1) and HTLV-2 infection among different populations in Brazil.
    Gabbai AA, Bordin JO, Vieira-Filho JP, Kuroda A, Oliveira AS, Cruz MV, Ribeiro AA, Delaney SR, Henrard DR, Rosario J.
    Am J Trop Med Hyg; 1993 Dec; 49(6):664-71. PubMed ID: 8279633
    [Abstract] [Full Text] [Related]

  • 22. Relation between human T-lymphotropic virus type I and neurologic diseases in Panama: 1985-1990.
    Gracia F, Castillo LC, Larreategui M, Roberts B, Cedeño V, Heneine W, Blattner W, Kaplan JE, Levine PH.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct 01; 10(2):192-7. PubMed ID: 7552485
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Seroepidemiology of human T-cell lymphotropic virus type I/II in northeastern Brazil.
    Moreira ED, Ribeiro TT, Swanson P, Sampaio Filho C, Melo A, Brites C, Badaró R, Toedter G, Lee H, Harrington W.
    J Acquir Immune Defic Syndr (1988); 1993 Aug 01; 6(8):959-63. PubMed ID: 8315579
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe. The HTLV European Research Network.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Sep 01; 13(1):68-77. PubMed ID: 8797688
    [Abstract] [Full Text] [Related]

  • 29. No proof of HTLV-I/II in intravenous drug abusers with a high rate of HIV-1 infection in central Thailand.
    Saguanwongse S, Muangpom A, Ruchusatsawat N, Wongcheree S, Warachit P, Miyamura K, Yamazaki S, Honda M.
    Microbiol Immunol; 1996 Sep 01; 40(9):639-44. PubMed ID: 8908608
    [Abstract] [Full Text] [Related]

  • 30. Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection. Women's Interagency HIV Study.
    Telzak EE, Hershow R, Kalish LA, Hardy WD, Zuckerman E, Levine A, Delapenha R, DeHovitz J, Greenblatt RM, Anastos K.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec 15; 19(5):513-8. PubMed ID: 9859966
    [Abstract] [Full Text] [Related]

  • 31. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
    Wang HR, Yan YS, Zhang QW, Zheng J, Liu JM, Feng YY, Wu SQ, Wu JH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May 15; 25(5):428-30. PubMed ID: 15231172
    [Abstract] [Full Text] [Related]

  • 32. Human T-lymphotropic virus type II seroprevalence among emergency department and clinic patients.
    Agranoff D, Varney K, Khayam-Bashi H, Murphy EL.
    West J Med; 1996 Jun 15; 164(6):481-5. PubMed ID: 8764621
    [Abstract] [Full Text] [Related]

  • 33. Human T cell lymphotropic virus infection in Guaymi Indians from Panama.
    Reeves WC, Cutler JR, Gracia F, Kaplan JE, Castillo L, Hartley TM, Brenes MM, Larreategui M, Loo de Lao S, Archbold C.
    Am J Trop Med Hyg; 1990 Oct 15; 43(4):410-8. PubMed ID: 2240369
    [Abstract] [Full Text] [Related]

  • 34. Risk factors for HTLV-I and II in individuals attending a clinic for sexually transmitted diseases.
    Giuliani M, Rezza G, Lepri AC, Di Carlo A, Maini A, Crescimbeni E, Palamara G, Prignano G, Caprilli F.
    Sex Transm Dis; 2000 Feb 15; 27(2):87-92. PubMed ID: 10676975
    [Abstract] [Full Text] [Related]

  • 35. Low prevalence of human T-cell leukaemia virus-I and -II infection among drug users in Amsterdam, The Netherlands.
    van den Hoek JA, Al EJ, Huisman JG, Goudsmit J, Coutinho RA.
    J Med Virol; 1991 Jun 15; 34(2):100-3. PubMed ID: 1890409
    [Abstract] [Full Text] [Related]

  • 36. HTLV-I and -II in intravenous drug users from Sweden and Denmark.
    Blomberg J, Moestrup T, Frimand J, Hansson BG, Krogsgaard K, Grillner L, Nordenfelt E.
    Scand J Infect Dis; 1994 Jun 15; 26(1):23-6. PubMed ID: 8191236
    [Abstract] [Full Text] [Related]

  • 37. HTLV-I and HTLV-II infections in hematologic disorder patients, cancer patients, and healthy individuals from Rio de Janeiro, Brazil.
    Farias de Carvalho SM, Pombo de Oliveira MS, Thuler LC, Rios M, Coelho RC, Rubim LC, Silva EM, Reis AM, Catovsky D.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jul 01; 15(3):238-42. PubMed ID: 9257659
    [Abstract] [Full Text] [Related]

  • 38. HTLV infections among Swedish intravenous drug users in 1992.
    Andersson S, Krook A, Käll K, Julander I, Thorstensson R, Biberfeld G.
    Scand J Infect Dis; 1995 Jul 01; 27(6):547-50. PubMed ID: 8685631
    [Abstract] [Full Text] [Related]

  • 39. Prevalence and risk factors for HTLV-II infection in 913 injecting drug users in Stockholm, 1994.
    Krook A, Albert J, Andersson S, Biberfeld G, Blomberg J, Eklund I, Engström A, Julander I, Käll K, Martin C, Stendahl P, Struve J, Sönnerborg A.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Aug 15; 15(5):381-6. PubMed ID: 9342259
    [Abstract] [Full Text] [Related]

  • 40. High prevalence of human T-lymphotropic virus (HTLV) infection in pregnant women in southern France.
    Vignoli C, De Lamballerie X, Zandotti C, De Chesse R, Tamalet C, De Micco P.
    Eur J Epidemiol; 1995 Feb 15; 11(1):93-4. PubMed ID: 7489782
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.